Neuropsychopharmacology
- Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants1 month ago
- Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers1 month ago
- Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective1 month ago
- A new prism next to motherhood’s light: uncovering changes in neural function following childbirth1 month ago
- Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry1 month ago
- Basal forebrain-lateral habenula inputs and control of impulsive behavior1 month ago
- Concurrent and longitudinal neurostructural correlates of irritability in children1 month ago
Journal of Psychopharmacology
- Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age2 months ago
- Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers2 months ago
- Re-visiting the association between antidepressant use and the risk of lung cancer2 months ago
- Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder2 months ago
- Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk2 months ago
- Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment2 months ago
- Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing2 months ago
European Neuropsychopharmacology
- Forget me not: The effect of doxycycline on human declarative memory3 weeks ago
- GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review2 months ago
- Treatment or enhancement? The controversial role of medication in personality disorders2 months ago
- Ensuring safety in cannabinoid prescriptions: A call for critical assessment2 months ago
- Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition2 months ago
- Childhood maltreatment: A call for a standardised definition and applied framework2 months ago
- Deciphering the impact of metabolic anomalies in relation to severe mental illness2 months ago